GUTolution is a longevity Biotech company helping to prevent and mitigate chronic conditions (Metabolic dysfunction–associated steatotic liver disease, various cancers, and more!). We leverage the latest technology (Metagenomic Next-Generation Sequencing), AI, and novel research with leading universities to achieve this. We provide convenient at-home test kits, an easy to use web/mobile app, one-on-one consultations with in-house experts, and custom made probiotics which are uniquely formulated to each individual’s needs. We partner with healthcare providers, insurance companies, wellness companies, gyms, old age/care homes, as well as distributors, dietitians, etc., to educate clients and improve both physical and mental health via improved gut health.
Rin Vinner leads scientific and strategic initiatives at GUTolution, a pioneering Hong Kong-based biotech start-up that uses metagenomic sequencing and AI-driven analysis to personalize gut microbiome wellness. Positioned within the Hong Kong Science Park’s Ideation Programme, GUTolution delivers at-home gut testing, personalized lifestyle insights, and custom probiotic formulations designed for real-world, everyday wellbeing, without making diagnostic or treatment claims.
Backed by top-tier innovation recognition, including HKSTP Incubation, the HK Tech 300 Seed Fund, JUMPSTARTER Global Top 100, and entrepreneurial awards—GUTolution brings rigor and credibility to its next-generation health solutions.
Rin is actively exploring strategic partnerships across Belt and Road markets, focusing on distribution, co-development with wellness or lifestyle platforms, and clinical research collaborations. She seeks synergies with digital health innovators, manufacturing partners, and ecosystem collaborators to expand access to microbiome-informed wellness across Asia.
At the Summit, Rin is committed to building meaningful collaborations and bringing GUTolution’s uniquely affordable and scientifically-grounded, personalized wellness offerings to cross-border markets.